论文部分内容阅读
目的探讨宫颈癌治疗中联合新辅助化疗的临床疗效及意义。方法选取从2009年3月至2011年12月在我院进行治疗的189例宫颈癌的患者作为研究对象,均为Ⅰb～Ⅱb期宫颈癌患者,采用PVB方案进行化疗2个疗程后,所有患者均进行手术治疗。结果手术前189例宫颈癌患者经过PVB两个疗程的化疗后,可以观察到完全缓解43例,部分缓解85例,稳定33例,进展28例,总治愈率85.19%。术后发现淋巴结转移9例。结论宫颈癌进行治疗时联合新辅助化疗取得了较好的临床疗效,转移率下降,值得临床推广。
Objective To investigate the clinical efficacy and significance of neoadjuvant chemotherapy in the treatment of cervical cancer. Methods A total of 189 patients with cervical cancer who were treated in our hospital from March 2009 to December 2011 were selected as stage Ⅰb-Ⅱb cervical cancer patients. After 2 cycles of chemotherapy with PVB regimen, all patients All were surgical treatment. Results 189 cases of cervical cancer before surgery after PVB two courses of chemotherapy, we can observe the complete remission in 43 cases, 85 cases were partially relieved, stable in 33 cases, progress in 28 cases, the total cure rate was 85.19%. Postoperative lymph node metastasis was found in 9 cases. Conclusion Cervical cancer treatment with neoadjuvant chemotherapy has achieved good clinical efficacy, metastasis rate, worthy of clinical promotion.